Drug benefit design is increasingly complex. The number of drugs on the market is growing, and decisions about program structure, cost sharing, formulary design, and…
When high-deductible health plans (HDHPs) were introduced in the early 2000s, many expected a new era of healthcare consumerism. HDHPs were expected to foster improved…
The latest insights on specialty drug spend and trend across pharmacy and medical benefits The sixth annual State of Specialty Spend and Trend Report analyzes…
Employers need to strike the right balance when making decisions about specialty drug benefits. So much of the conversation around specialty drugs, understandably, tend to…
New to market formulary blocks (NTMBs) are increasingly prevalent strategies pharmacy benefit managers (PBMs) are using to control specialty prescription drug costs. NTMBs bar certain newly released…
Employers are navigating a fast-changing landscape of specialty drug benefits. Specialty drug patients now make up 4% of commercially insured member populations as of 2020,…
Overview Over 30% of plan sponsors are exploring alternate models driven mostly by high-cost specialty medications and the need to reduce inappropriate utilization. Right now,…
What is cystic fibrosis? People tend to consider cystic fibrosis (CF) a pediatric disease; however, it can also affect adults. CF is an autosomal recessive…
Would you be surprised to learn specialty drug trend slowed in 2020 compared to recent years? Unfortunately, we know that the pandemic likely impacted trend…
In recent weeks, Express Scripts (ESI) released their list of January 1, 2022 formulary changes for their National Preferred Formulary and National Preferred Flex Formulary.